Advertisement
Screener

Altamira Therapeutics Ltd. (CYTOF) Form 6-K: Report of foreign private issuer, 2021

Altamira Therapeutics Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2021-12-16: Form 6-K; Period of report 2021-12-16; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea152486-6k_altamiratherap.htm.
  • 2021-09-08: Form 6-K; Period of report 2021-06-30; Description CURRENT REPORT OF PRIVATE ISSUER; Document ea146756-6k_altamira.htm.
  • 2021-07-23: Form 6-K; Period of report 2021-07-22; Description CURRENT REPORT; Document ea144644-6k_aurismedical.htm.
  • 2021-07-21: Form 6-K; Period of report 2021-07-21; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea144544-6k_aurismedical.htm.
FiledFormPeriod of reportDescriptionDocument
2021-12-166-K2021-12-16REPORT OF FOREIGN PRIVATE ISSUERea152486-6k_altamiratherap.htm
2021-09-086-K2021-06-30CURRENT REPORT OF PRIVATE ISSUERea146756-6k_altamira.htm
2021-07-236-K2021-07-22CURRENT REPORTea144644-6k_aurismedical.htm
2021-07-216-K2021-07-21REPORT OF FOREIGN PRIVATE ISSUERea144544-6k_aurismedical.htm
2021-06-166-K2021-06-16REPORT OF FOREIGN PRIVATE ISSUERea142646-6k_aurismedical.htm
2021-06-036-K2021-06-03FORM 6-Kea142050-6k_aurismedical.htm
2021-05-176-K2021-05-17REPORT OF FOREIGN PRIVATE ISSUERea141042-6k_aurismedical.htm
2021-04-166-K2021-04-16REPORT OF FOREIGN PRIVATE ISSUERea139558-6k_aurismedical.htm
2021-04-136-K2021-04-13CURRENT REPORTea139403-6k_aurismedical.htm
2021-03-316-K2021-03-31REPORT OF FOREIGN PRIVATE ISSUERea138738-6k_aurismedical.htm
2021-03-126-K2021-03-12REPORT OF FOREIGN PRIVATE ISSUERea137561-6k_aurismedical.htm
2021-01-156-K2021-01-15REPORT OF FOREIGN PRIVATE ISSUERea133382-6k_aurismedical.htm